Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Macular Oedema
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Fluocinolone 190microgram Iluvien®
(Intravitreal Implant )
Eye, Corticosteroids, 11.04.01
RED
Ranibizumab 10mg/ml intravitreal injection
(Intravitreal Injection )
Eye, Subfoveal choroidal neovascularisation, 11.08.02
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Aflibercept
Aflibercept [Specialist Drug]
Eye, Antineoplastic Drugs, Antineoplastics, Other
Macular Oedema, Retinopathy Of Prematurity
Aflibercept
Aflibercept [Specialist Drug]
Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Macular Oedema, Retinopathy Of Prematurity
Brolucizumab
Brolucizumab [Specialist Drug]
Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Oedema
Dexamethasone
Dexamethasone
Eye, Corticosteroids
Retinal Disorders, Macular Oedema
Faricimab
Faricimab [Specialist Drug]
Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Oedema
Fluocinolone
Fluocinolone Acetonide
Eye, Corticosteroids
Retinal Disorders, Macular Oedema
Ranibizumab
Ranibizumab [Specialist Drug]
Eye, Antineovascularisation Drugs, Vascular Endothelial Growth Factor Inhibitors
Retinal Disorders, Macular Oedema, Diabetic Retinopathy, Retinopathy Of Prematurity
Links found
NICE TA1004: Faricimab for treating visual impairment caused by macular oedema after retinal vein occlusion
NICE TA229: Dexamethasone intravitreal implant for the treatment of macular oedema
NICE TA274: Macular oedema (diabetic) - ranibizumab
NICE TA283: Macular oedema (retinal vein occlusion) - ranibizumab: guidance
NICE TA301: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (replaced by NICE TA953)
NICE TA305: Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion
NICE TA346: Aflibercept for treating diabetic macular oedema
NICE TA349: Dexamethasone intravitreal implant for treating diabetic macular oedema
NICE TA613: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy (replaced by NICE TA953)
NICE TA799 Faricimab for treating diabetic macular oedema
NICE TA820: Brolucizumab for treating diabetic macular oedema
NICE TA824: Dexamethasone intravitreal implant for treating diabetic macular oedema
NICE TA953: Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema